Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.17660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Ran Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anus Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Flotillin‐1(FLOT1) has long been recognized as a tumour‐promoting gene in several types of cancer. However, the expression and function of FLOT1 in glioblastomas (GBM) has not been elucidated. Here, in this study, we find that the expression level of FLOT1 in GBM tissue was much higher than that in normal brain, and the expression was even higher in the more aggressive subtypes and IDH status of glioma. Kaplan–Meier survival revealed that high FLOT1 expression is closely associated with poor outcome in GBM patients. FLOT1 knockdown markedly reduced the proliferation, migration and invasiveness of GBM cells, while FLOT1 overexpression significantly increases GBM cell proliferation, migration and invasiveness. Mechanistically, FLOT1 expression may play a potential role in the microenvironment of GBM. Therefore, FLOT1 promotes GBM proliferation and invasion in vitro and in vivo and may serve as a biomarker of prognosis and therapeutic potential in the fight against GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal and Anus Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- The Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Neurosurgery, Dengzhou People's Hospital, Dengzhou, Henan, China.
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Ran Wang, Qing Liu, Xiangyu Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, R., Chen, Z., Zhang, Y., Xiao, S., Zhang, W., Hu, X., Xiao, Q., Liu, Q., & Wang, X. (2023). Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17660
Vancouver
Wang R, Chen Z, Zhang Y, Xiao S, Zhang W, Hu X, et al. Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17660
BibTeX
@article{Wang2023,
author = {Wang, Ran and Chen, Zhikang and Zhang, Yi and Xiao, Shihan and Zhang, Wuming and Hu, Xianqin and Xiao, Qun and Liu, Qing and Wang, Xiangyu},
title = {Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.17660}
}
EUVIMED